Value of early metabolic response for predicting axillary pathological complete response during neoadjuvant systemic therapy in triple negative and HER2-amplified breast cancers: impact of tumor subtypes

Abstract Background In the era of therapeutic de-escalation, the opportunity to move from systematic axillary lymph node dissection (ALND) to sentinel lymph node biopsy in axillary node-positive breast cancer patients after neoadjuvant systemic therapy (NST) is currently considered. The purpose of t...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Loup Guichard, Prescillia Nunes, Clémentine Jankowski, Aurélie Bertaut, Eloïse Michel, Sylvain Ladoire, Charles Coutant, Alexandre Cochet, Jean-Louis Alberini
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	BMC 2025-09-01
Reeks:	Cancer Imaging
Onderwerpen:	Breast cancer Neoadjuvant therapy FDG PET Axillary lymph node Response monitoring Tumor subtype
Online toegang:	https://doi.org/10.1186/s40644-025-00914-9
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!